INSIGHTS ON CLINICAL TRIAL PARTNERING

• Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development

  Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.

• Why Should Site Agility Be Your Next Competitive Advantage?

  Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.

• 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives

  AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

• How a Biopharmaceutical Company Improved Site Satisfaction

  Eliminate site payment delays and reduce clinical trial admin burden. Learn how one sponsor cut payment timelines from 120+ days to under 30 days while boosting site satisfaction.

• Multi-Site Capabilities For Your Phase I-II Trials

  5/1/2026

  Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired patient populations.

• Four Trends In Obesity Clinical Trials

  7/22/2026

  Retention, body composition, maintenance therapy, amylin combinations, and behavioral support are reshaping obesity trials. Learn how sponsors can reduce dropout risk and strengthen clinical data.

• Overcoming Unexpected Obstacles In A Phase 1 Study

  1/29/2025

  Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.

• Global Trials Can't Afford To Overlook Africa

  9/3/2025

  Africa’s trial capacity is growing, but patient services remain the key to retention and reliable outcomes. Sponsors that act now can shape Africa into a true global trial hub.

• State of Materiovigilance: Gaps, Technology & Outsourcing

  5/12/2026

  Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.